Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Hims & Hers Health, Inc. Class A Common Stock
(NY:
HIMS
)
39.20
-0.82 (-2.05%)
Official Closing Price
Updated: 7:00 PM EST, Dec 5, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Hims & Hers Health, Inc. Class A Common Stock
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
48
49
Next >
3 Top Stocks Crushing Q3 Earnings With Strong 2024 Guidance
November 12, 2024
Hims & Hers, Payoneer, and Astera Labs lead Q3 earnings with standout revenue growth, forecast upgrades, and strategic wins—stocks to watch for growth potential
Via
MarketBeat
Tesla, Trump Trades, And Tech: Top Stocks To Watch Today
↗
November 11, 2024
With TSLA pushing for $260 and HIMS at all-time highs, today’s movers are primed for action. Here’s what’s driving these gains.
Via
Talk Markets
Topics
Government
MARA Holdings, RadNet, Bit Digital, Coinbase And Other Big Stocks Moving Higher On Monday
↗
November 11, 2024
Via
Benzinga
We Tested Top Stocks; Here’s What’s Best For Your Money
↗
November 10, 2024
Discover the top-performing stocks with our analysis. In this video, we dive into the Bollinger Band Squeeze strategy while scanning for opportunities.
Via
Talk Markets
Why HIMS & HERS HEALTH INC (NYSE:HIMS) qualifies as a high growth stock.
↗
November 07, 2024
Is HIMS & HERS HEALTH INC (NYSE:HIMS) suited for growth investing?
Via
Chartmill
Assessing Hims & Hers Health: Insights From 7 Financial Analysts
↗
November 06, 2024
Via
Benzinga
Decoding Hims & Hers Health's Options Activity: What's the Big Picture?
↗
November 04, 2024
Via
Benzinga
Stock Market Surges To Highs On Trump Election; Fed Cuts Rates, Palantir Soars: Weekly Review
↗
November 08, 2024
A Fed rate cut and a slew of big earnings reports filled out a busy week.
Via
Investor's Business Daily
Topics
Economy
Government
After Another Blowout Quarter of Surging Revenue, Is Hims & Hers Stock a Once-in-a-Decade Buy?
↗
November 08, 2024
Hims & Hers strong performance involves much more than just GLP-1 drugs.
Via
The Motley Fool
Missed Out on Eli Lilly? Buy This Amazing Growth Stock Instead
↗
November 06, 2024
The company expects to enjoy many GLP-1 tailwinds in 2025.
Via
The Motley Fool
Hims & Hers: Why This Healthcare Stock’s Growth Makes It a Buy
November 06, 2024
According to analysts, even after a 6% rally on the morning of the earnings announcement, Hims & Hers stock might still be a buy today.
Via
MarketBeat
Topics
ETFs
Economy
Smart Money Is Betting Big In HIMS Options
↗
October 30, 2024
Via
Benzinga
A Look Into Hims & Hers Health Inc's Price Over Earnings
↗
October 22, 2024
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
↗
November 05, 2024
Via
Benzinga
What's Going On With Hims & Hers Health Stock Tuesday?
↗
November 05, 2024
Hims & Hers Health Inc. (NYSE: HIMS) shares are trading higher Tuesday after the company reported strong third-quarter results and raised its full-year revenue outlook. Here's what you need to know.
Via
Benzinga
Charter Communications To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Tuesday
↗
November 05, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
November 05, 2024
Via
Benzinga
Palantir, Trump Media, Hims & Hers Health, NXP Semiconductors, And Tesla: Why These 5 Stocks Are On Investors' Radars Today
↗
November 04, 2024
The U.S. stock market experienced a slight downturn on Monday, with the S&P 500 index dipping approximately 0.3%. The Dow Jones Industrial Average fell 0.6% to 41,794.60.
Via
Benzinga
Topics
Government
Stocks
How Is The Market Feeling About Hims & Hers Health?
↗
October 22, 2024
Via
Benzinga
Hims & Hers Health Reports Better-Than-Expected Q3 Results: Details
↗
November 04, 2024
Hims & Hers Health reported its third-quarter results after Monday's closing bell. Here's a look at the details from the report.
Via
Benzinga
IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory
↗
November 04, 2024
Hims stock jumped late Monday after the online pharmacy beat expectations.
Via
Investor's Business Daily
Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results
November 04, 2024
From
Hims & Hers
Via
Business Wire
What's Going On With Hims & Hers Health Stock Monday?
↗
November 04, 2024
Hims & Hers Health will report third-quarter financial results after the market close on Monday. Analysts expect the company to report earnings of 4 cents per share and revenue of $382.2 million,...
Via
Benzinga
Hims & Hers Health Stock Is Trading Lower Wednesday: Here's Why
↗
October 30, 2024
Hims & Hers Health shares are falling Thursday following an FDA update listing Novo Nordisk diabetes drug Ozempic and weight-loss drug Wegovy as available, signaling possible supply stability. Here's...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
↗
October 30, 2024
Via
Benzinga
Could This Magnificent Pharma Stock 10x in the Next 5 Years?
↗
October 30, 2024
Disrupting pharmacies is just the start for Hims & Hers.
Via
The Motley Fool
How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals
October 29, 2024
From
Hims & Hers
Via
Business Wire
Top 3 Stocks Institutions Are Buying Right Now
October 28, 2024
Despite the stock market trading at new all-time highs, institutions still find enough reason to buy more enormous stakes in three stocks.
Via
MarketBeat
Hims & Hers Stock Dropped: Here's What You Need to Know
↗
October 24, 2024
The GLP-1 drama continues at Hims & Hers.
Via
The Motley Fool
Ozempic And Wegovy Maker Novo Nordisk Asks FDA To Halt Production Of Compounded Fat Loss Drugs Due To Their 'Inherent Complexity'
↗
October 23, 2024
Via
Benzinga
< Previous
1
2
...
27
28
29
30
31
32
33
34
35
...
48
49
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
